Protein Binding Assays Market Size, Type, Regions, and Major Companies Application To 2026

OCT 04, 2019: The global protein binding assays market size is expected to reach USD 683.09 million by 2026 at a CAGR of 10.6%, according to a new report by Radiant Insights, Inc. Protein binding assays are increasingly being adopted in preclinical stages of drug discovery & development programs. These assays help in detection of target molecules and provide critical information about the properties of therapeutics and biologics.

To Request A Sample Copy Of This Report @:   https://www.radiantinsights.com/research/protein-binding-assays-market/request-sample

Increase in number of R&D outsourcing activities by pharmaceutical companies for development of therapeutics is anticipated to increase the adoption of protein binding assays. Presence of several companies that provide these services for molecule investigation and analysis is expected to positively impact the market growth over the forecast period.

These assays provide help understand ADME properties during selection and development of therapeutic candidates. Estimation of safety margins during drug development is an important step that can be carried out by quantification of binding of new chemical entities to a protein.

Further key findings from the report suggest:

• Equilibrium dialysis accounted for the largest share and is expected to maintain its dominance over the forecast period

• This is because equilibrium dialysis is an extensively used method to detect free drug fraction as it is less susceptible to experimental artifacts

• Instruments segment is expected to grow at the fastest CAGR due to rising demand for automated, user-friendly systems that help determine the distribution capacity of drug candidates

• Assay services offered by a large number of biotechnology players can be attributed to the segment’s largest revenue share in 2018

• Increase in number of CROs offering customized, comprehensive, and economical protein binding assay services to support pharmaceutical firms is expected to boost growth of CROs segment

• Pharmaceutical firms are investing significantly in preclinical drug discovery studies to meet the growing demand for therapeutics resulting in the largest protein binding assays market share of the segment

• Presence of leading players providing such assays and high R&D investment for therapeutic development can be attributed to the dominant share of North Americ

• Asia Pacific is expected to witness fastest growth due to low cost of preclinical methods, which increases outsourcing of services to the region

• Companies such as Thermo Fisher, Charles River, Sovicell, GE Healthcare, Evotec, and others have undertaken several strategic initiatives to enhance their market presence

To Browse Full Research Report @:https://www.radiantinsights.com/research/protein-binding-assays-market

Table of Content

Chapter 1 Executive Summary

1.1 Protein Binding Assays Market Outlook, 2015 – 2026

1.2 Protein Binding Assays Market: Segment Outlook, 2015 – 2026

1.3 Protein Binding Assays Market: Competitive Insights

Chapter 2 Research Methodology & Scope

2.1 Information Procurement

2.2 Information or Data Analysis

2.3 Market Formulation & Validation

Chapter 3 Protein Binding Assays Market Variables, Trends & Scope

3.1 Industry Pyramid Analysis

3.2 Penetration & Growth Prospect Mapping for Technology, 2018

3.3 Protein Binding Assays Market: Technology Overview

3.4 Protein Binding Assays Market: Market Dynamics

3.4.1 Market driver analysis

3.4.1.1 Increase in adoption of protein binding assays in drug discovery & development

3.4.1.2 High rate of late stage drug failure

3.4.1.3 Substantial number of CROs operating in the space

3.4.2 Market restraint analysis

3.4.2.1 Challenges pertaining to standardization of assay designing

3.4.3 Market challenges analysis

3.4.3.1 Introduction of in-silico prediction techniques

3.5 Industry Analysis – Porter’s

3.6 Protein Binding Assays Market – SWOT Analysis, by Factor (Political & Legal, Economic, And Technological)

3.7 Major Deals & Strategic Alliances Analysis

3.7.1 Mergers & acquisitions

3.7.2 Collaborations & partnership

3.7.3 Agreement

Chapter 4 Protein Binding Assays Market Categorization: Technology Estimates & Trend Analysis

4.1 Protein Binding Assays Market: Technology Movement Analysis, 2018 & 2026

4.2 Ultracentrifugation

4.2.1 Global protein binding assays market by ultracentrifugation, 2015 – 2026 (USD Million)

4.3 Equilibrium Dialysis

4.3.1 Global protein binding assays market by equilibrium dialysis, 2015 – 2026 (USD Million)

4.4 Ultrafiltration

4.4.1 Global protein binding assays market by ultrafiltration, 2015 – 2026 (USD Million)

4.5 Surface Plasmon Resonance

4.5.1 Global protein binding assays market by surface plasmon resonance, 2015 – 2026 (USD Million)

4.6 Other Technologies

4.6.1 Global protein binding assays market by other technologies, 2015 – 2026 (USD Million)

Continued….

To See More Reports of This Category by Radiant Insights:
https://www.radiantinsights.com/catalog/biotechnology

About Radiant Insights:Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. It assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. The Organization has a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

Media Contact:Company Name: Radiant Insights, Inc
Contact Person: Michelle Thoras
Email: sales@radiantinsights.com
Phone: (415) 349-0054
Address: 201 Spear St #1100, Suite #3036
City: San Francisco
State: California
Country: United States
For more information, Visit: http://www.radiantinsights.com